+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Healthcare-associated Infectious Disease Diagnostics Market Research Report by Product & Service, by Disease Type, by End-user, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5181418
  • Report
  • January 2022
  • Region: Global
  • 188 Pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Co-Diagnostics Inc.
  • DiaSorin S.p.A.
  • GNA Biosolutions GmbH
  • Meridian Bioscience Inc.
  • Roche Holding AG
The Global Healthcare-associated Infectious Disease Diagnostics Market size was estimated at USD 3,207.26 million in 2020, is expected to reach USD 3,458.33 million in 2021, and is projected to grow at a CAGR of 8.19% to reach USD 5,566.14 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Healthcare-associated Infectious Disease Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market was studied across Assays, Kits, & Reagents, Instruments, and Services & Software.
  • Based on Disease Type, the market was studied across Chlamydia Trachomatis Genital Infection and Gonorrhea, Hepatitis, Hospital-Acquired Infections, Human Immunodeficiency Virus, Human Papillomavirus, Influenza, and Tuberculosis.
  • Based on End-user, the market was studied across Academic/Research Institutes, Hospital/Clinical Laboratories, Physician Offices, and Reference Laboratories.
  • Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare-associated Infectious Disease Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Healthcare-associated Infectious Disease Diagnostics Market, including Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux SA, Co-Diagnostics Inc., Danaher Corporation, DiaSorin S.p.A., DNAe Group Holdings Ltd, GNA Biosolutions GmbH, Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Roche Holding AG, Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Healthcare-associated Infectious Disease Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare-associated Infectious Disease Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare-associated Infectious Disease Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Healthcare-associated Infectious Disease Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Healthcare-associated Infectious Disease Diagnostics Market?
6. What is the market share of the leading vendors in the Global Healthcare-associated Infectious Disease Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Healthcare-associated Infectious Disease Diagnostics Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Co-Diagnostics Inc.
  • DiaSorin S.p.A.
  • GNA Biosolutions GmbH
  • Meridian Bioscience Inc.
  • Roche Holding AG
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Shift in focus from centralized laboratories to decentralized point-of-care testing
5.1.1.2. Shift in focus from centralized laboratories to decentralized point-of-care testing
5.1.1.3. Growth in funding for research on infectious disease diagnostics
5.1.2. Restraints
5.1.2.1. Stringent regulations to prevent HAIs in healthcare settings
5.1.2.2. Sophisticated mechanisms available to control HAIs
5.1.3. Opportunities
5.1.3.1. Increase in target patients with healthcare-associated infections
5.1.3.2. High growth potential in low and middle-income countries
5.1.3.3. Growing penetration of POC tests to diagnose HAIs
5.1.4. Challenges
5.1.4.1. Inadequate reimbursements
5.1.4.2. Low prevalence of HAIs in high-income nations
5.2. Cumulative Impact of COVID-19

6. Healthcare-associated Infectious Disease Diagnostics Market, by Product & Service
6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Instruments
6.4. Services & Software

7. Healthcare-associated Infectious Disease Diagnostics Market, by Disease Type
7.1. Introduction
7.2. Chlamydia Trachomatis Genital Infection and Gonorrhea
7.3. Hepatitis
7.4. Hospital-Acquired Infections
7.5. Human Immunodeficiency Virus
7.6. Human Papillomavirus
7.7. Influenza
7.8. Tuberculosis

8. Healthcare-associated Infectious Disease Diagnostics Market, by End-user
8.1. Introduction
8.2. Academic/Research Institutes
8.3. Hospital/Clinical Laboratories
8.4. Physician Offices
8.5. Reference Laboratories

9. Americas Healthcare-associated Infectious Disease Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Becton, Dickinson and Company
13.3. Bio-Rad Laboratories, Inc.
13.4. Biomérieux SA
13.5. Co-Diagnostics Inc.
13.6. Danaher Corporation
13.7. DiaSorin S.p.A.
13.8. DNAe Group Holdings Ltd
13.9. GNA Biosolutions GmbH
13.10. Luminex Corporation
13.11. Meridian Bioscience Inc.
13.12. Quidel Corporation
13.13. Roche Holding AG
13.14. Siemens Healthineers AG
13.15. Thermo Fisher Scientific Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing


List of Figures
Figure 1. Global Healthcare-Associated Infectious Disease Diagnostics Market: Research Process
Figure 2. Global Healthcare-Associated Infectious Disease Diagnostics Market: Market Dynamics
Figure 3. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Product & Service, 2020 Vs 2027 (%)
Figure 4. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Product & Service, 2020 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Product & Service, 2027
Figure 6. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Assays, Kits, & Reagents, 2018-2027 (USD Million)
Figure 7. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Assays, Kits, & Reagents, by Region, 2020 Vs 2027 (USD Million)
Figure 8. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Instruments, 2018-2027 (USD Million)
Figure 9. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Instruments, by Region, 2020 Vs 2027 (USD Million)
Figure 10. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Services & Software, 2018-2027 (USD Million)
Figure 11. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Services & Software, by Region, 2020 Vs 2027 (USD Million)
Figure 12. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Disease Type, 2020 Vs 2027 (%)
Figure 13. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Disease Type, 2020 Vs 2027 (USD Million)
Figure 14. Competitive Strategic Window For Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Disease Type, 2027
Figure 15. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Chlamydia Trachomatis Genital Infection And Gonorrhea, 2018-2027 (USD Million)
Figure 16. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Chlamydia Trachomatis Genital Infection And Gonorrhea, by Region, 2020 Vs 2027 (USD Million)
Figure 17. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hepatitis, 2018-2027 (USD Million)
Figure 18. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hepatitis, by Region, 2020 Vs 2027 (USD Million)
Figure 19. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hospital-Acquired Infections, 2018-2027 (USD Million)
Figure 20. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hospital-Acquired Infections, by Region, 2020 Vs 2027 (USD Million)
Figure 21. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Human Immunodeficiency Virus, 2018-2027 (USD Million)
Figure 22. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Human Immunodeficiency Virus, by Region, 2020 Vs 2027 (USD Million)
Figure 23. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Human Papillomavirus, 2018-2027 (USD Million)
Figure 24. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Human Papillomavirus, by Region, 2020 Vs 2027 (USD Million)
Figure 25. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Influenza, 2018-2027 (USD Million)
Figure 26. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Influenza, by Region, 2020 Vs 2027 (USD Million)
Figure 27. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Tuberculosis, 2018-2027 (USD Million)
Figure 28. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Tuberculosis, by Region, 2020 Vs 2027 (USD Million)
Figure 29. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by End-User, 2020 Vs 2027 (%)
Figure 30. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by End-User, 2020 Vs 2027 (USD Million)
Figure 31. Competitive Strategic Window For Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by End-User, 2027
Figure 32. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Academic/Research Institutes, 2018-2027 (USD Million)
Figure 33. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Academic/Research Institutes, by Region, 2020 Vs 2027 (USD Million)
Figure 34. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hospital/Clinical Laboratories, 2018-2027 (USD Million)
Figure 35. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hospital/Clinical Laboratories, by Region, 2020 Vs 2027 (USD Million)
Figure 36. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Physician Offices, 2018-2027 (USD Million)
Figure 37. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Physician Offices, by Region, 2020 Vs 2027 (USD Million)
Figure 38. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Reference Laboratories, 2018-2027 (USD Million)
Figure 39. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Reference Laboratories, by Region, 2020 Vs 2027 (USD Million)
Figure 40. Americas Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 41. Argentina Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 42. Brazil Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 43. Canada Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 44. Mexico Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 45. United States Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 46. Asia-Pacific Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 47. Australia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 48. China Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 49. India Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 50. Indonesia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 51. Japan Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 52. Malaysia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 53. Philippines Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 54. Singapore Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 55. South Korea Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 56. Taiwan Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 57. Thailand Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 58. Europe, Middle East & Africa Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 59. France Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 60. Germany Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 61. Italy Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 62. Netherlands Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 63. Qatar Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 64. Russia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 65. Saudi Arabia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 66. South Africa Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 67. Spain Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 68. United Arab Emirates Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 69. United Kingdom Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Figure 70. Global Healthcare-Associated Infectious Disease Diagnostics Market: Fpnv Positioning Matrix
Figure 71. Global Healthcare-Associated Infectious Disease Diagnostics Market: Share, by Key Player, 2020
Figure 72. Competitive Scenario Analysis In Global Healthcare-Associated Infectious Disease Diagnostics Market, by Type


List of Tables
Table 1. Global Healthcare-Associated Infectious Disease Diagnostics Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 (USD Million)
Table 4. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Assays, Kits, & Reagents, by Region, 2018-2027 (USD Million)
Table 5. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Instruments, by Region, 2018-2027 (USD Million)
Table 6. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Services & Software, by Region, 2018-2027 (USD Million)
Table 7. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 (USD Million)
Table 8. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Chlamydia Trachomatis Genital Infection And Gonorrhea, by Region, 2018-2027 (USD Million)
Table 9. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hepatitis, by Region, 2018-2027 (USD Million)
Table 10. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hospital-Acquired Infections, by Region, 2018-2027 (USD Million)
Table 11. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Human Immunodeficiency Virus, by Region, 2018-2027 (USD Million)
Table 12. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Human Papillomavirus, by Region, 2018-2027 (USD Million)
Table 13. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Influenza, by Region, 2018-2027 (USD Million)
Table 14. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Tuberculosis, by Region, 2018-2027 (USD Million)
Table 15. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by End-User, 2018-2027 (USD Million)
Table 16. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Academic/Research Institutes, by Region, 2018-2027 (USD Million)
Table 17. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Hospital/Clinical Laboratories, by Region, 2018-2027 (USD Million)
Table 18. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Physician Offices, by Region, 2018-2027 (USD Million)
Table 19. Global Healthcare-Associated Infectious Disease Diagnostics Market Size, by Reference Laboratories, by Region, 2018-2027 (USD Million)
Table 20. Americas Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 21. Argentina Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 22. Brazil Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 23. Canada Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 24. Mexico Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 25. United States Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 26. Asia-Pacific Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 27. Australia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 28. China Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 29. India Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 30. Indonesia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 31. Japan Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 32. Malaysia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 33. Philippines Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 34. Singapore Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 35. South Korea Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 36. Taiwan Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 37. Thailand Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 38. Europe, Middle East & Africa Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 39. France Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 40. Germany Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 41. Italy Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 42. Netherlands Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 43. Qatar Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 44. Russia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 45. Saudi Arabia Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 46. South Africa Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 47. Spain Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 48. United Arab Emirates Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 49. United Kingdom Healthcare-Associated Infectious Disease Diagnostics Market Size, 2018-2027 (USD Million)
Table 50. Global Healthcare-Associated Infectious Disease Diagnostics Market: Scores
Table 51. Global Healthcare-Associated Infectious Disease Diagnostics Market: Business Strategy
Table 52. Global Healthcare-Associated Infectious Disease Diagnostics Market: Product Satisfaction
Table 53. Global Healthcare-Associated Infectious Disease Diagnostics Market: Ranking
Table 54. Global Healthcare-Associated Infectious Disease Diagnostics Market: Share, by Key Player, 2020
Table 55. Global Healthcare-Associated Infectious Disease Diagnostics Market: Merger & Acquisition
Table 56. Global Healthcare-Associated Infectious Disease Diagnostics Market: Agreement, Collaboration, & Partnership
Table 57. Global Healthcare-Associated Infectious Disease Diagnostics Market: New Product Launch & Enhancement
Table 58. Global Healthcare-Associated Infectious Disease Diagnostics Market: Investment & Funding
Table 59. Global Healthcare-Associated Infectious Disease Diagnostics Market: Award, Recognition, & Expansion
Table 60. Global Healthcare-Associated Infectious Disease Diagnostics Market: License & Pricing
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • Co-Diagnostics Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • DNAe Group Holdings Ltd
  • GNA Biosolutions GmbH
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Roche Holding AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...